Skip to content
akaturk Academic measurement
2021 SJR Q2 JCR Q3 · 3 5 matched articles

Journal detail

Hormones and Cancer

Publisher
Springer US
Country
United States · Northern America
Type
journal
ISSN
  • 18688497
  • 18688500
Scopus 0,558 SJR
Scopus Q2 SJR Q
WoS Q3 JCR Q
WoS 3 JIF
Scopus 0 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,558
  • Quartile Q2
  • H-Index 0
  • Cites/doc 0
  • Docs (3y) 0
  • Cites (3y) 0

Clarivate

Web of Science · JCR · 2022

  • JCR Q Q3
  • JIF 3
  • 5Y JIF 3,2
  • JCI 0,68

Subject classification

Categories (SJR)

  • Cancer Research Q3
  • Endocrine and Autonomic Systems Q3
  • Endocrinology Q3
  • Endocrinology, Diabetes and Metabolism Q3
  • Medicine (miscellaneous) Q2
  • Oncology Q3

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine
  • Neuroscience

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2022 — Q3 — 3 3,2 0,68 Q2 —
2021 Q2 Q2 0,558 4,7 3,6 0,71 Q2 0
2020 Q2 Q3 0,981 3,9 3,2 0,64 Q3 0
2019 Q2 Q3 0,716 2,4 2,6 0,59 Q3 0
2018 — Q3 — 2,2 2,6 0,61 Q3 —
2017 Q2 Q3 1,251 2,6 2,9 0,72 Q2 0
2016 Q1 Q2 1,394 3,7 — — — 0
2015 Q1 Q2 1,49 3,2 — — — 0
2014 Q1 Q3 1,42 2,2 — — — 0
2013 Q1 — 1,606 — — — — 0
2012 Q1 — 1,12 — — — — 0
2011 Q3 — 0,31 — — — — 0

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2022 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 99/145
2022 ONCOLOGY SCIE Q3 Q2 157/241
2021 ENDOCRINOLOGY & METABOLISM SCIE Q2 Q2 58/146
2021 ONCOLOGY SCIE Q2 Q2 107/245
2020 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 78/146
2020 ONCOLOGY SCIE Q3 Q3 137/242
2019 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 101/143
2019 ONCOLOGY SCIE Q3 Q3 171/244
2018 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q3 106/145
2018 ONCOLOGY SCIE Q3 Q3 169/230
2017 ENDOCRINOLOGY & METABOLISM SCIE Q3 Q2 87/142
2017 ONCOLOGY SCIE Q3 Q2 143/223
2016 ENDOCRINOLOGY & METABOLISM SCIE Q2 — 44/138
2016 ONCOLOGY SCIE Q2 — 77/217
2015 ENDOCRINOLOGY & METABOLISM SCIE Q2 — 54/133
2015 ONCOLOGY SCIE Q2 — 90/213
2014 ENDOCRINOLOGY & METABOLISM SCIE Q3 — 85/128
2014 ONCOLOGY SCIE Q3 — 145/211